Logo

American Heart Association

  3
  0


Final ID: Sa1109

Aerobic Capacity of Adults with Fontan Palliation: Disease-specific Reference Values and Relationship to Outcomes

Abstract Body: Background: Patients with Fontan palliation have reduced aerobic capacity because of impaired cardiac, pulmonary, and skeletal muscle function. However, the assessment of aerobic capacity in this population still relies on comparisons with people without cardiovascular disease, rather than comparison with the expected aerobic capacity of other Fontan patients. The purpose of this study was to determine the expected aerobic capacity of adults with Fontan palliation.
Method: Adults with Fontan palliation who underwent cardiopulmonary exercise test at Mayo Clinic (2003-2023) were stratified into quartiles based on the predicted peak VO2. We assessed the correlates of predicted peak VO2, and the relationship between predicted peak VO2 quartiles and cardiovascular outcomes (death/transplant).
Results: Of 323 patients (age 29±9 years; 177 [55%] men), the median peak VO2 was 19.1 (15.2 - 23.9) ml/kg/min, and this corresponds to a predicted peak VO2 of 51% (range 19 -88; interquartile range 41 - 62). The correlates of higher predicted peak VO2 were smaller body mass index, higher systemic saturation, and lower Fontan pressures. The top, 2nd,3rd, and bottom quartile of predicted peak VO2 corresponds to predicted peak VO2 of 63-88%, 51-62%, 41-50%, and 19-40%, respectively. Using the top quartile as the reference, the 3rd quartile (HR 1.13, 95% CI 1.03-1.28, p=0.02), and 4th quartile were associated with a higher risk of death/transplant (HR 1.32, 95% CI 1.16-1.69, p<0.001).
Conclusions: The results of the current study would help calibrate the interpretation of exercise test data in adults with Fontan palliation and improve risk stratification in this population.
  • Ali, Ahmed  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Goda, Ahmed  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Abozied, Omar  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Egbe, Alexander  ( Mayo Clinic , Rochester , Minnesota , United States )
  • Author Disclosures:
    Ahmed Ali: DO NOT have relevant financial relationships | Ahmed Goda: DO NOT have relevant financial relationships | Omar Abozied: No Answer | Alexander Egbe: No Answer
Meeting Info:

Resuscitation Science Symposium

2024

Chicago, Illinois

Session Info:

ReSS24 Poster Session 111: Neurologic and Other than Injury After Cardiac Arrest

Saturday, 11/16/2024 , 05:15PM - 06:45PM

ReSS24 Poster Session and Reception

More abstracts on this topic:
Fontan-Associated Liver Disease On A Chip

Rezapourdamanab Sarah, Dasi Lakshmi, Romero Rene, Bauser Heaton Holly, Serpooshan Vahid, Singh Yamini, Norton Sophia, Hwang Boeun, Jin Linqi, Salar Amoli Mehdi, Karnik Shweta, Avazmohammadi Reza, Neelakantan Sunder

The metabolic landscape of Fontan-associated liver disease

Sule Rasheed, Hu Po, Petucci Chris, Wilkins Benjamin, Rychik Jack, Pei Liming

You have to be authorized to contact abstract author. Please, Login
Not Available